Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia

Published:2024-09 Issue:9 Volume:30 Page:923.e1-923.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Jung Dawoon^ORCID,Long-Boyle Janel R.,Pang Wendy W.^ORCID,Gobburu Jogarao V.S.^ORCID

Publisher

Elsevier BV

Reference18 articles.

1. Low exposure busulfan conditioning to achieve sufficient multilineage chimerism in patients with severe combined immunodeficiency;Dvorak;Biol Blood Marrow Transplant,2019

2. hematopoietic stem cell transplantation for severe combined immunodeficiency;Wahlstrom;Curr Pediatr Rep,2015

3. Expectations and experience: parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID);Smith;Clin Immunol,2021

4. Gene therapy for SCID, now up to 3!;Fischer;J Allergy Clin Immunol,2023

5. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival;Myers;Blood,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP